Prototype Device for Hearing Loss in Infants

(SEFR Trial)

This trial tests a newly developed prototype device that measures how infant brains respond to speech sounds. Researchers aim to determine if the device can detect differences in brain responses between infants with hearing loss and those with normal hearing, both with and without hearing aids. It suits infants aged 3 to 24 months who have either normal hearing or hearing loss and have been fitted with hearing aids. The study involves up to two sessions where the device records brain responses to speech sounds. As an unphased trial, this study offers a unique opportunity for infants to contribute to groundbreaking research that could enhance early detection and intervention for hearing loss.

The trial information does not specify whether participants need to stop taking their current medications.

Research shows that the new device for measuring brain responses in infants is a unique tool for checking hearing. Although specific safety data for this device is unavailable, hearing assessment tools for infants are generally considered low-risk. These tools are usually non-invasive, meaning they don't enter the body or cause harm.

In this trial, the device measures how infants' brains react to sounds without altering any hearing aid settings. This involves recording responses during one or two sessions. Since the device only records, it likely poses minimal risk to participants.

Researchers are excited about the newly developed prototype device for hearing loss in infants because it offers a novel way to assess and potentially aid hearing in infants who are too young for traditional hearing tests. Unlike typical hearing aids and cochlear implants, which are standard treatments for hearing loss and require fitting and surgical procedures, this device uses speech-evoked envelope following responses (EFRs) to evaluate and support hearing responses in both normal and hearing-impaired infants. This non-invasive approach could provide a quicker, more accurate assessment of an infant's hearing capabilities and help tailor more effective interventions early on, possibly improving long-term auditory outcomes.

This trial tests a newly developed prototype device designed to measure how infants' brains respond to speech sounds. The device aims to differentiate between brain responses in infants with normal hearing and those with hearing loss. Early results suggest that similar devices, which use technology to detect hearing problems in infants, have proven accurate and effective. Previous studies have shown that these devices can reliably identify hearing loss by analyzing infants' responses to sound. This method could help detect hearing issues early, allowing for timely treatment.²⁶⁷⁸⁹